Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

Deep-pocketed investors have adopted a bullish approach towards Merck & Co MRK, and it's something market players shouldn't ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $144.12, a high estimate of $155 ...

Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

Charlie CY Yang, an analyst from Bank of America Securities, maintained the Buy rating on Merck & Company (MRK – Research Report).

The annual overnight camping trip for Mettawee sixth graders does not go unnoticed by the rest of the students. “We saw how ...

Low-volatility stocks are attractive now because they provide stability and reduce risk during market downturns, delivering ...

Emory researchers are the first to show unprecedented control of SIV replication and decay of viral reservoirs by combining a ...

Merck Animal Health recently awarded $90,000 in scholarships to nine aspiring bovine veterinarians in collaboration with the ...

Researchers have shown unprecedented control of SIV replication and decay of viral reservoirs by combining a stringent model of infection with the interruption of antiretroviral therapy (ART). The ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.